• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.27% Nasdaq Up 1.56%

    CytRx Corporation (CYTR)

    -NasdaqCM
    2.37 Up 0.08(3.49%) 3:00PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.29
    Open:2.32
    Bid:2.36 x 4700
    Ask:2.37 x 2100
    1y Target Est:8.50
    Beta:3.33129
    Earnings Date:Nov 2 - Nov 6 (Est.)
    Day's Range:2.26 - 2.39
    52wk Range:1.98 - 5.42
    Volume:236,101
    Avg Vol (3m):823,677
    Market Cap:157.56M
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTR

    Comparison

    Symbol% ChgMkt Cap
    CYTRUp 3.49%157.56M
    LLYUp 1.32%85.62B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,522.39
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.99
    Quarterly EPS Est (Sep-15) :-0.24
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate is aldoxorubicin, which is in Phase III clinical trial as a therapy for patients with soft tissue sar... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback